Healio (6/29, Gramigna) reports, “Adjunctive ganaxolone appeared to reduce persistent depression among postmenopausal women,” investigators concluded after collecting and analyzing “data from December 2016 to April 2018 of 10 postmenopausal women aged 53 years to 69 years with persistent depression despite adequate antidepressant treatment.” The findings of the “open-label, uncontrolled pilot study” were published online June 9 in the Journal of Clinical Psychiatry.(SOURCE: APA Headlines)